Artificial Intelligence in Healthcare Market Size, Share & Growth 2033

Artificial Intelligence in Healthcare Market is segmented By Product Type (Hardware, Software, Services), By Technology (Speech recognition, Natural language processing, Machine learning, Disaster recovery, Others), By Application (Imaging & diagnostics, Drug discovery, Precision medicine, Hospital management, Insights & risk analytics, Wearables, Virtual assistants, Healthcare assistant robots, Others), By End-User (Hospitals, Pharmaceutical Company, Diagnostic Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Last Updated: || Author: Rohan Sawant || Reviewed: Akshay Reddy || SKU: HCIT728

Report Summary
Table of Contents
List of Tables & Figures

Market Size

The Global Artificial Intelligence in Healthcare Market reached US$ 37,331.9 million in 2025 and is projected to witness lucrative growth by reaching up to US$ 373,269.8 million by 2033. The market is growing at a CAGR of 41.1% during the forecast period (2026-2033).

Artificial intelligence in healthcare is a rapidly growing sector that is transforming the way healthcare services are delivered. AI technology is being applied to a wide range of healthcare applications, from diagnostic tools to drug discovery to patient monitoring and care management.

The market for AI in healthcare is expected to grow significantly in the coming years, driven by factors such as the increasing healthcare data being generated, the need for improved patient outcomes, and the growing demand for cost-effective healthcare solutions.

Market Summary

MetricsDetails
CAGR41.1%
Size Available for Years2023-2033
Forecast Period2026-2033
Data AvailabilityValue (US$) and Volume (Tons)
Segments CoveredProduct Type, Technology, Application, End-User, and Region
Regions CoveredNorth America, Europe, Asia-Pacific, South America, and Middle East & Africa
Fastest Growing RegionAsia-Pacific
Largest RegionNorth America
Report Insights CoveredCompetitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Type Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.

 

To Know More Request Free Sample

Market Dynamics

Growing demand for advanced technologies that can improve patient results and simplify hospital processes drives the growth of the market

The global market for artificial intelligence in healthcare is expanding as a result of the spike in research and development activities due to the rising incidence of chronic disorders. Artificial intelligence-enhanced technology can analyze data much more quickly than a human can, including clinical research, medical records, and genetic data that can aid in diagnosis. Numerous repetitive jobs, including data entry, record keeping, and scan processing, can be automated with Artificial intelligence. AI in healthcare enables medical workers to take informed decisions on the basis of precise information, which saves time, lowers costs, and generally improves the administration of medical records. There are numerous key players developing these products to provide better treatment to patients. The government's laws and policies supporting artificial intelligence in healthcare are driving the market growth.

Rising expenditure for research and development proficiencies creates lucrative growth opportunities  for manufacturers 

There is a growing market opportunity due to the expanding adoption of artificial intelligence in healthcare and rising investments by developing and developed nations for medical devices & instruments as a result of the rising prevalence of chronic disorders. People are facing issues with various kinds of disorders due to which demand for early diagnosis is increasing. A rise in public-private funding for focused research projects, a rise in the need for better healthcare services as a result of an unbalanced patient-to-healthcare worker ratio, and a rise in product innovations & development of technologically advanced products are going to create opportunities for artificial intelligence. Increasing expenditures in healthcare infrastructure and the development of cutting-edge technologies such as machine learning and natural language processing are contributing to the growth of artificial intelligence in healthcare market. Hence, producers must invest in R&D to develop new, improved products and meet rising demand. The major businesses are investing a lot of time in research and development to provide new systems with various novel advancements.

Market Segment Analysis

The global artificial intelligence in healthcare market is segmented based on product type, technology, application, end-user, and region.

The rising adoption of artificial intelligence is driving the growth of the software segment

Artificial intelligence is more software-based than hardware-based computer programs. Through numerous insights and data patterns, it enables computer systems to emulate human actions. It uses a variety of technologies, including natural language processing, deep learning, neural networks, and machine learning. It aids in the creation of programs like chatbots, virtual assistants, programs for speech and voice recognition, image recognition, and others. 

When machine learning and AI technologies are integrated together, users can use the features and functionality they need to complete business activities quickly and easily. Software for artificial intelligence can be accessed online. Anyone can access it through any device having an internet connection; it does not require to be installed on the computer. Software with artificial intelligence is unique. AI businesses sell access to their own data sets and algorithms rather than software licenses for use. This indicates that all one needs to use it is an internet connection-neither hardware nor infrastructure. The cutting-edge software Philips IntelliSpace AI Workflow Suite is made specifically for radiology. The package is intended to complement Philips' dedication to offering open, all-inclusive solutions for the AI imaging needs of healthcare practitioners.

Market Geographical Share

North America has a strong presence of major players and increasing healthcare infrastructure investment

Due to the rising need for technological advancements in healthcare, in North America, manufacturers have the opportunity to enhance their operations. There are many producers and suppliers in North America, and owing to the quick economic growth of the region, industrial production has expanded, driving up the demand for machine learning in healthcare. Increasing expenditure on healthcare and rising awareness among people, advancement of AI software and services in healthcare, and increase in pharmaceutical establishment across the region are also contributing to the market growth in this region. Government initiatives to support various artificial intelligence in healthcare initiatives for people with illnesses also drive market growth. 

Furthermore, the fast-growing population and rising cancer prevalence has increased demand for innovative technologies in artificial intelligence. The above-mentioned factors drive the growth of the North America artificial intelligence in healthcare market.

Artificial Intelligence in Healthcare Companies

The major global players in the market include Intel Corporation, Koninklijke Philips N.V., Microsoft, Siemens Healthcare GmbH, NVIDIA Corporation, IBM, Labcor Laboratórios Ltd., Medtronic, Google and Micron Technology, Inc.

Key Developments

February 2026: Rising adoption of AI-powered diagnostics, predictive analytics, and virtual healthcare assistants accelerated growth in the global Artificial Intelligence in Healthcare market across North America, Europe, and Asia-Pacific. Companies increasingly expanded AI healthcare platforms, while strategic investments in advanced healthcare AI technologies strengthened long-term digital health transformation and clinical efficiency.

January 2026: Increasing adoption of AI-enabled medical imaging, robotic surgery systems, and personalized treatment solutions strengthened innovation in the Artificial Intelligence in Healthcare market across the United States, China, Germany, and Japan. Healthcare providers focused on improving patient outcomes, operational efficiency, and next-generation precision medicine technologies.

December 2025: Growing emphasis on digital healthcare infrastructure, chronic disease management, and data-driven clinical decision-making accelerated investments in AI healthcare projects across Europe, North America, and Asia-Pacific. Governments and healthcare organizations increasingly focused on supply chain modernization, healthcare automation, and sustainable digital transformation strategies.

November 2025: Expansion of telemedicine platforms, remote patient monitoring systems, and smart hospital infrastructure across Asia-Pacific and North America supported rising demand for artificial intelligence in healthcare globally. Companies expanded applications in diagnostics, drug discovery, and patient engagement, while increasing investments in advanced healthcare infrastructure and intelligent care delivery systems.

October 2025: Rising advancements in machine learning, natural language processing, AI-enabled wearable devices, and multimodal healthcare systems improved operational efficiency in the Artificial Intelligence in Healthcare market across the United States, Europe, and China. Research organizations increasingly focused on smart healthcare technologies, predictive care systems, and low-cost digital healthcare solutions.

September 2025: Increasing collaborations between healthcare providers, pharmaceutical companies, and AI technology firms accelerated development in the artificial intelligence healthcare industry across Europe, North America, and Asia-Pacific. Companies focused on strategic partnerships, commercialization of AI-driven healthcare applications, and expansion of personalized medicine solutions.

August 2025: Growing investments in healthcare data platforms, cloud-based AI systems, and automated clinical workflows strengthened expansion of the Artificial Intelligence in Healthcare market across China, India, the United States, and Europe. Enterprises increasingly adopted digital monitoring systems, AI-assisted diagnostics, and automated healthcare management technologies.

July 2025: Rising focus on healthcare automation, operational efficiency, and AI-assisted patient care accelerated market developments across global healthcare markets. Analysts highlighted growing demand for remote healthcare services, predictive analytics, and intelligent healthcare applications as major growth drivers.

June 2025: Increasing demand from hospitals, pharmaceutical companies, diagnostics centers, and telehealth providers supported strong growth in the global Artificial Intelligence in Healthcare market. North America remained the leading region, while Asia-Pacific emerged as a rapidly growing market supported by digital healthcare expansion, rising healthcare investments, and increasing adoption of advanced AI technologies.

Why Purchase the Report?

  • To visualize the global artificial intelligence in healthcare- market segmentation based on product type, technology, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of artificial intelligence in healthcare market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global artificial intelligence in healthcare market report would provide approximately 53 tables, 54 figures and 195 Pages.

Why purchase Artificial Intelligence in Healthcare Market report?

Technological Innovations

Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.

Product Performance & Market Positioning

Analyzes product performance, market positioning, and growth potential to optimize strategies.

Real-World Evidence

Integrates patient feedback and data into product development for improved outcomes.

Physician Preferences & Health System Impact

Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.

Market Updates & Industry Changes

Covers recent regulatory changes, new policies, and emerging technologies.

Competitive Strategies

Analyzes competitor strategies, market share, and emerging players.

Pricing & Market Access

Reviews pricing models, reimbursement trends, and market access strategies.

Market Entry & Expansion

Identifies optimal strategies for entering new markets and partnerships.

Regional Growth & Investment

Highlights high-growth regions and investment opportunities.

Supply Chain Optimization

Assesses supply chain risks and distribution strategies for efficient product delivery.

Sustainability & Regulatory Impact

Focuses on eco-friendly practices and evolving regulations in healthcare.

Post-market Surveillance

Uses post-market data to enhance product safety and access.

Pharmacoeconomics & Value-Based Pricing

Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2026

Manufacturers

Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.

Regulatory & Policy

Compliance Officers, Government, Health Economists, Market Access Specialists.

Application & Innovation

AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.

Investors

Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.

Consulting & Advisory

Healthcare Consultants, Industry Associations, Analysts.

Supply Chain

Distribution and Supply Chain Managers.

Consumers & Advocacy

Patients, Advocacy Groups, Insurance Companies.

Academic & Research

Academic Institutions.

Save 20% on all licenses
Single User$4350$3480Multi User$4850$3880Corporate$7850$6280

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
FAQ’s

  • The Global Artificial Intelligence in Healthcare Market reached US$ 37,331.9 million in 2025 and is projected to witness lucrative growth by reaching up to US$ 373,269.8 million by 2033. The market is growing at a CAGR of 41.1% during the forecast period (2026-2033).

  • The market is expected to grow at a CAGR of 41.1% during the forecast period.

  • North America holds the largest market share, while Asia-Pacific is the fastest growing region.

  • Rising healthcare data, need for better patient outcomes, cost-effective solutions, and government support are key drivers.

  • Key companies include Microsoft, Google, Intel, IBM, NVIDIA, Philips, Siemens Healthcare, and Medtronic.
PDF
DataM
Artificial Intelligence in Healthcare Market Report
SKU: HCIT728

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports